"Cell therapy in Asia has been gathering momentum over the past several years. Japan accelerated its position as a hub for regenerative medicine research, largely driven by support from Prime Minister Shinzo Abe, who identified regenerative medicine and cellular therapy as key to the Japan’s strategy to drive economic growth.
China, South Korea, and other Asian nations have also taken measures to support cell therapy development within their borders."
Expect more deals out of Asia imo.
I also think RGS signed the best deal.
RGS Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held